Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system

References

• FeizizadehSSalehi-AbargoueiAAkbariVEfficacy and safety of Saccharomyces boulardii for acute diarrheaPediatrics20141341e176e19124958586
   PubMed Web of Science ®Google Scholar
• McFarlandLVMeta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile diseaseAm J Gastroenterol2006101481282216635227
   PubMed Web of Science ®Google Scholar
• McFarlandLVMeta-analysis of probiotics for the prevention of traveler’s diarrheaTravel Med Infect Dis2007529710517298915
   PubMedGoogle Scholar
• SazawalSHiremathGDhingraUMalikPDebSBlackREEfficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trialsLancet Infect Dis20066637438216728323
   PubMed Web of Science ®Google Scholar
• MoréMISwidsinskiASaccharomyces boulardii CNCM i-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis‚ a reviewClin Exp Gastroenterol2015823725526316791
   PubMedGoogle Scholar
• ButsJPTwenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectivesDig Dis Sci2009541151818528758
   PubMed Web of Science ®Google Scholar
• ButsJPDe KeyserNInteraction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects?J Pediatr Gastroenterol Nutr201051453253320706146
   PubMed Web of Science ®Google Scholar
• JahnHUUllrichRSchneiderTImmunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteersDigestion1996572951048786007
   PubMed Web of Science ®Google Scholar
• PothoulakisCKellyCPJoshiMASaccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileumGastroenterology19931044110811158462799
   PubMed Web of Science ®Google Scholar
• CastagliuoloIRieglerMFValenickLLaMontJTPothoulakisCSaccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosaInfect Immun19996713023079864230
   PubMed Web of Science ®Google Scholar
• CastagliuoloILaMontJTNikulassonSTPothoulakisCSaccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileumInfect Immun19966412522552328945570
   PubMed Web of Science ®Google Scholar
• MartinsFSDalmassoGArantesRMEInteraction of Saccharomyces boulardii with Salmonella enterica serovar typhimurium protects mice and modifies T84 cell response to the infectionPLoS One201051e892520111723
   PubMed Web of Science ®Google Scholar
• MartinsFSVieiraAlTElianSDInhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in miceMicrobes Infect201315427027923376166
   PubMed Web of Science ®Google Scholar
• Pontier-BresRMunroPBoyerLSaccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tractPLoS One201498e10306925118595
   PubMed Web of Science ®Google Scholar
• PothoulakisCReview article: anti-inflammatory mechanisms of action of Saccharomyces boulardiiAliment Pharmacol Ther200930882683319706150
   PubMed Web of Science ®Google Scholar
• Edwards-IngramLGitshamPBurtonNGenotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiaeAppl Environ Microbiol20077382458246717293506
   PubMed Web of Science ®Google Scholar
• CascioVGittingsDMerloniKHurtonMLapradeDAustriacoNS-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell deathBMC Microbiol2013133523402325
   PubMed Web of Science ®Google Scholar
• FiettoJLAraujoRSValadaoFNMolecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardiiCan J Microbiol200450861562115467787
   PubMed Web of Science ®Google Scholar
• DinleyiciECKaraAOzenMVandenplasYSaccharomyces boulardii CNCM I-745 in different clinical conditionsExpert Opin Biol Ther201414111593160924995675
   PubMed Web of Science ®Google Scholar
• CebraJJPeriwalSBLeeGLeeFShroffKEDevelopment and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and virusesDev Immunol199861–213189716901
   PubMedGoogle Scholar
• RoundJLMazmanianSKThe gut microbiota shapes intestinal immune responses during health and diseaseNat Rev Immunol20099531332319343057
   PubMed Web of Science ®Google Scholar
• MantisNJRolNCorthesyBSecretory IgA’s complex roles in immunity and mucosal homeostasis in the gutMucosal Immunol20114660361121975936
   PubMed Web of Science ®Google Scholar
• MartinsFSSilvaAAVieiraATComparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic propertiesArch Microbiol2009191862363019526225
   PubMed Web of Science ®Google Scholar
• RodriguesACCaraDCFretezSHSaccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic miceJ Appl Microbiol200089340441411021572
   PubMed Web of Science ®Google Scholar
• QamarAAboudolaSWarnyMSaccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in miceInfect Immun20016942762276511254650
   PubMed Web of Science ®Google Scholar
• ButsJPBernasconiPVaermanJPDiveCStimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardiiDig Dis Sci19903522512562302983
   PubMed Web of Science ®Google Scholar
• CaetanoJMParamesMBaboMImmunopharmacological effects of Saccharomyces boulardii in healthy human volunteersInt J Immunopharmacol1986832452593733298
   PubMed Web of Science ®Google Scholar
• BadiaRZanelloGChevaleyreCEffect of Saccharomyces cerevisiae var. Boulardii and beta-galactomannan oligosaccharide on porcine intestinal epithelial and dendritic cells challenged in vitro with Escherichia coli F4 (K88)Vet Res201243422277078
   PubMed Web of Science ®Google Scholar
• SmithIMChristensenJEArneborgNJespersenLYeast modulation of human dendritic cell cytokine secretion: an in vitro studyPLoS One201495e9659524816850
   PubMed Web of Science ®Google Scholar
• BadiaRBrufauMTGuerrero-ZamoraAMBeta-galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cellsClin Vaccine Immunol201219336837622301691
   PubMedGoogle Scholar
• JawharaSHabibKMaggiottoFModulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractionsPLoS One201277e4064822848391
   PubMed Web of Science ®Google Scholar
• BohnJABeMillerJN(1→3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationshipsCarbohyd Poly199528314
   Web of Science ®Google Scholar
• BrownGDHerreJWilliamsDLWillmentJAMarshallASGordonSDectin-1 mediates the biological effects of beta-glucansJ Exp Med200319791119112412719478
   PubMed Web of Science ®Google Scholar
• ChanGCChanWKSzeDMThe effects of beta-glucan on human immune and cancer cellsJ Hematol Oncol200922519515245
   PubMed Web of Science ®Google Scholar
• RicePJAdamsELOzment-SkeltonTOral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challengeJ Pharmacol Exp Ther200531431079108615976018
   PubMed Web of Science ®Google Scholar
• KankkunenPTeirilaLRintahakaJAleniusHWolffHMatikainenS(1,3)-Beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophagesJ Immunol2011184116335634220421639
   PubMed Web of Science ®Google Scholar
• StierHEbbeskotteVGruenwaldJImmune-modulatory effects of dietary yeast beta-1,3/1,6-D-glucanNutr J20141313824774968
   PubMed Web of Science ®Google Scholar
• IlievIDFunariVATaylorKDInteractions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitisScience201233660861314131722674328
   PubMed Web of Science ®Google Scholar
• NguyenYSperandioVEnterohemorrhagic E. coli (EHEC) pathogenesisFront Cell Infect Microbiol201229022919681
   PubMed Web of Science ®Google Scholar
• BielaszewskaMAldickTBauwensAKarchHHemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulenceInt J Med Microbiol20143045–652152924933303
   PubMed Web of Science ®Google Scholar
• CordeiroFda SilvaRIVargas-StampeTLCerqueiraAMAndradeJRCell invasion and survival of Shiga toxin-producing Escherichia coli within cultured human intestinal epithelial cellsMicrobiology2013159Pt 81683169423704791
   PubMed Web of Science ®Google Scholar
• DalmassoGLoubatADahanSCalleGRampalPCzeruckaDSaccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cellsRes Microbiol2006157545646516487684
   PubMed Web of Science ®Google Scholar
• Barnett FosterDAbul-MilhMHuescaMLingwoodCAEnterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leafletInfect Immun20006863108311510816451
   PubMed Web of Science ®Google Scholar
• DahanSDalmassoGImbertVPeyronJFRampalPCzeruckaDSaccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cellsInfect Immun200371276677312540556
   PubMed Web of Science ®Google Scholar
• SougioultzisSSimeonidisSBhaskarKRSaccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expressionBiochem Biophys Res Commun20063431697616529714
   PubMed Web of Science ®Google Scholar
• GuignotJSeguraATran Van NhieuGThe serine protease EspC from enteropathogenic Escherichia coli regulates pore formation and cyto-toxicity mediated by the type III secretion systemPLoS Pathog2015117e100501326132339
   PubMed Web of Science ®Google Scholar
• CraneJKMajumdarSPickhardtDF3rdHost cell death due to enteropathogenic Escherichia coli has features of apoptosisInfect Immun19996752575258410225923
   PubMed Web of Science ®Google Scholar
• GlotfeltyLGHechtGAEnteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanismsAnn N Y Acad Sci2012125814915822731728
   PubMed Web of Science ®Google Scholar
• CzeruckaDDahanSMograbiBRossiBRampalPSaccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cellsInfect Immun200068105998600410992512
   PubMed Web of Science ®Google Scholar
• GuptaSKKeckJRamPKCrumpJAMillerMAMintzEDPart III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005Epidemiol Infect2008136672173817686197
   PubMed Web of Science ®Google Scholar
• FairbrotherJMNadeauEGylesCLEscherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategiesAnim Health Res Rev200561173916164007
   PubMedGoogle Scholar
• LessardMDupuisMGagnonNAdministration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challengeJ Anim Sci200987392293419028865
   PubMed Web of Science ®Google Scholar
• ThomasSPrzesdzingIMetzkeDSchmitzJRadbruchABaumgartDCSaccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferationClin Exp Immunol20091561788719161443
   PubMed Web of Science ®Google Scholar
• ButsJPDekeyserNStilmantCDelemESmetsFSokalESaccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylationPediatr Res2006601242916690953
   PubMed Web of Science ®Google Scholar
• HobbieSChenLMDavisRJGalanJEInvolvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cellsJ Immunol199715911555055599548496
   PubMed Web of Science ®Google Scholar
• HurleyDMcCuskerMPFanningSMartinsMSalmonella-host interactions – modulation of the host innate immune systemFront Immunol2014548125339955
   PubMed Web of Science ®Google Scholar
• AshidaHMimuroHSasakawaCShigella manipulates host immune responses by delivering effector proteins with specific rolesFront Immunol2015621925999954
   PubMed Web of Science ®Google Scholar
• JennisonAVVermaNKShigella flexneri infection: pathogenesis and vaccine developmentFEMS Microbiol Rev2004281435814975529
   PubMed Web of Science ®Google Scholar
• MumyKLChenXKellyCPMcCormickBASaccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling eventsAm J Physiol Gastrointest Liver Physiol20082943G599G60918032477
   PubMed Web of Science ®Google Scholar
• RodriguesACNardiRMBambirraEAVieiraECNicoliJREffect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic miceJ Appl Bacteriol19968132512568810053
   PubMedGoogle Scholar
• BartlettJGClinical practice. Antibiotic-associated diarrheaN Engl J Med2002346533433911821511
   PubMed Web of Science ®Google Scholar
• ElmerGWMcFarlandLVSuppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamstersAntimicrob Agents Chemother19873111291313566236
   PubMed Web of Science ®Google Scholar
• ChenXKokkotouEGMustafaNSaccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritisJ Biol Chem200628134244492445416816386
   PubMed Web of Science ®Google Scholar
• ForsterJGuarinoAParezNHospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of agePediatrics20091233e393e40019254975
   PubMed Web of Science ®Google Scholar
• CorreaNBPennaFJLimaFMNicoliJRFilhoLATreatment of acute diarrhea with Saccharomyces boulardii in infantsJ Pediatr Gastroenterol Nutr201153549750121734600
   PubMed Web of Science ®Google Scholar
• BuccigrossiVLaudieroGRussoCChloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytesPLoS One201496e9983024918938
   PubMed Web of Science ®Google Scholar
• FidanIKalkanciAYesilyurtEEffects of Saccharomyces boulardii on cytokine secretion from intraepithelial lymphocytes infected by Escherichia coli and Candida albicansMycoses2009521293418627477
   PubMed Web of Science ®Google Scholar
• JawharaSPoulainDSaccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitisMed Mycol200745869170017885943
   PubMed Web of Science ®Google Scholar
• CalichVLPinaAFelonatoMBernardinoSCostaTALouresFVToll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosisFEMS Immunol Med Microbiol20085311718384366
   PubMedGoogle Scholar
• GirardPPansartYGillardinJMInducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in ratsNitric Oxide200513316316916039151
   PubMed Web of Science ®Google Scholar
• SoyturkMSaygiliSMBaskinHEffectiveness of Saccharomyces boulardii in a rat model of colitisWorld J Gastroenterol201218446452646023197891
   PubMed Web of Science ®Google Scholar
• KollaritschHHolstHGrobaraPWiedermannGProphylaxe der Reisediarrhöe mit Saccharomyces boulardii. Ergebnisse einer plazebokontrollierten Doppelblindstudie [Prevention of traveler’s diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study]Fortschr Med19931119152156 German8486328
   PubMedGoogle Scholar
• JohnsonSMaziadePJMcFarlandLVIs primary prevention of Clostridium difficile infection possible with specific probiotics?Int J Infect Dis20121611e786e79222863358
   PubMed Web of Science ®Google Scholar
• TungJMDolovichLRLeeCHPrevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic reviewCan J Gastroenterol2009231281782120011734
   PubMed Web of Science ®Google Scholar
• SzajewskaHMrukowiczJMeta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoeaAliment Pharmacol Ther200522536537216128673
   PubMed Web of Science ®Google Scholar
• KarpaKDProbiotics for Clostridium difficile diarrhea: putting it into perspectiveAnn Pharmacother20074171284128717595302
   PubMed Web of Science ®Google Scholar
• LhermTMonetCNougiereBSeven cases of fungemia with Saccharomyces boulardii in critically ill patientsIntensive Care Med200228679780112107689
   PubMed Web of Science ®Google Scholar
• McFarlandLVSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsWorld J Gastroenterol201016182202222220458757
   PubMed Web of Science ®Google Scholar
• McFarlandLVProbiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic reviewAntibiotics20154216017827025619
   PubMedGoogle Scholar
• LewisSJPottsLFBarryREThe lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patientsJ Infect19983621711749570649
   PubMed Web of Science ®Google Scholar
• OzkanTBSahinEErdemirGBudakFEffect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune responseJ Int Med Res200735220121217542407
   PubMed Web of Science ®Google Scholar
• Gil de los SantosJRStorchOBGil-TurnesCBacillus cereus var. toyoii and Saccharomyces boulardii increased feed efficiency in broilers infected with Salmonella enteritidisBr Poult Sci200546449449716268108
   PubMed Web of Science ®Google Scholar
• MountzourisKCDalakaEPalamidiIEvaluation of yeast dietary supplementation in broilers challenged or not with Salmonella on growth performance, cecal microbiota composition and Salmonella in ceca, cloacae and carcass skinPoult Sci201594102445245526286998
   PubMed Web of Science ®Google Scholar
• SzajewskaHHorvathAPiwowarczykAMeta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatmentAliment Pharmacol Ther20103291069107921039671
   PubMed Web of Science ®Google Scholar
• SakaryaSGunayNSaccharomyces boulardii expresses neuraminidase activity selective for alpha2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cellsAPMIS20141221094195024628732
   PubMed Web of Science ®Google Scholar
• DalmassoGCottrezFImbertVSaccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodesGastroenterology200613161812182517087945
   PubMed Web of Science ®Google Scholar
• BergRBernasconiPFowlerDGautreauxMInhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardiiJ Infect Dis19931685131413188228371
   PubMed Web of Science ®Google Scholar
• EverardAMatamorosSbGeurtsLDelzenneNMCaniPDSaccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db miceMBio201453e01011e0101424917595
   PubMed Web of Science ®Google Scholar
• RyanEPHeubergerALWeirTLBarnettBBroecklingCDPrenniJERice bran fermented with Saccharomyces boulardii generates novel metabolite profiles with bioactivityJ Agric Food Chem20115951862187021306106
   PubMed Web of Science ®Google Scholar
• ChenXFruehaufJGoldsmithJDSaccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in apcmin miceGastroenterology2009137391492319482027
   PubMed Web of Science ®Google Scholar